Literature DB >> 7687957

Antiepileptic drug mechanisms of action.

R L Macdonald1, K M Kelly.   

Abstract

Clinically used antiepileptic drugs (AEDs) decrease membrane excitability by interacting with ion channels or neurotransmitter receptors. Currently available AEDs appear to act on sodium channels, GABAA receptors, or calcium channels. Phenytoin, carbamazepine, and possibly valproate (VPA) decrease high-frequency repetitive firing of action potentials by enhancing sodium channel inactivation. Benzodiazepines and barbiturates enhance GABAA receptor-mediated inhibition. Ethosuximide and possibly VPA reduce a low-threshold calcium current. The mechanisms of action of AEDs currently under development are less clear. Lamotrigine may decrease sustained high-frequency repetitive firing. The mechanisms of action of felbamate are unknown. Gabapentin (GBP) appears to bind to a specific binding site in the central nervous system with a restricted regional distribution, but the identity of the binding site and the mechanism of action of GBP remain uncertain.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7687957     DOI: 10.1111/j.1528-1157.1993.tb05918.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  15 in total

1.  VOLTAGE-GATED CALCIUM CHANNELS ARE NOT AFFECTED BY THE NOVEL ANTI-EPILEPTIC DRUG LACOSAMIDE.

Authors:  Yuying Wang; Rajesh Khanna
Journal:  Transl Neurosci       Date:  2011-03       Impact factor: 1.757

2.  Molecular model of anticonvulsant drug binding to the voltage-gated sodium channel inner pore.

Authors:  Gregory M Lipkind; Harry A Fozzard
Journal:  Mol Pharmacol       Date:  2010-07-19       Impact factor: 4.436

3.  Protective effect of carbamazepine on kainic acid-induced neuronal cell death through activation of signal transducer and activator of transcription-3.

Authors:  Hae Jeong Park; Su Kang Kim; Joo-Ho Chung; Jong Woo Kim
Journal:  J Mol Neurosci       Date:  2012-07-08       Impact factor: 3.444

Review 4.  Antiepileptic drugs and mechanisms of epileptogenesis. A review.

Authors:  R Mutani; R Cantello; M Gianelli; C Civardi
Journal:  Ital J Neurol Sci       Date:  1995-05

5.  In vivo study of the effect of valpromide and valnoctamide in the pilocarpine rat model of focal epilepsy.

Authors:  H Lindekens; I Smolders; G M Khan; M Bialer; G Ebinger; Y Michotte
Journal:  Pharm Res       Date:  2000-11       Impact factor: 4.200

6.  Phenobarbital Versus Valproate for Generalized Convulsive Status Epilepticus in Adults: A Prospective Randomized Controlled Trial in China.

Authors:  Yingying Su; Gang Liu; Fei Tian; Guoping Ren; Mengdi Jiang; Brian Chun; Yunzhou Zhang; Yan Zhang; Hong Ye; Daiquan Gao; Weibi Chen
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

7.  The anticonvulsant BW534U87 depresses epileptiform activity in rat hippocampal slices by an adenosine-dependent mechanism and through inhibition of voltage-gated Na+ channels.

Authors:  J R Dupere; T J Dale; S J Starkey; X Xie
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

Review 8.  Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024.

Authors:  António F Ambrósio; Patrício Soares-Da-Silva; Caetana M Carvalho; Arsélio P Carvalho
Journal:  Neurochem Res       Date:  2002-02       Impact factor: 3.996

9.  Electrophysiological actions of felbamate on rat striatal neurones.

Authors:  A Pisani; A Stefani; A Siniscalchi; N B Mercuri; G Bernardi; P Calabresi
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

10.  Differential effects on fast and slow spindle activity, and the sleep slow oscillation in humans with carbamazepine and flunarizine to antagonize voltage-dependent Na+ and Ca2+ channel activity.

Authors:  Amr Ayoub; Dominic Aumann; Anne Hörschelmann; Atossa Kouchekmanesch; Pia Paul; Jan Born; Lisa Marshall
Journal:  Sleep       Date:  2013-06-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.